The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study - Waldherr, C; Pless, M; Maecke, H R (Ann Oncol, 2001)
et al.